It’s ‘never too late’ to prevent or delay dementia, international commission claims
By
Alicia Lasek
Jul 31, 2020
Up to 40% of dementia cases could be thwarted by modifying 12 key risk factors, according to a report by the Lancet Commission. Many of these factors can be tackled late in life, the authors say.
Highly accurate Alzheimer’s blood test a ‘breakthrough,’ observers say
By
Alicia Lasek
Jul 30, 2020
The experimental blood test rivals the accuracy of standard diagnostic methods and may soon prove to be a cost-effective, accessible tool in the clinical setting, according to some in the scientific community.
Exercise helps protect against Alzheimer’s and related decline
By
Alicia Lasek
Jul 18, 2019
Increased physical activity provides greater protection against cognitive decline and brain tissue loss. A moderate walking routine can help.
Nearly half of dementia patients exhibit apathy; researchers argue for better care
By
Alicia Lasek
Jul 17, 2019
Many residents with dementia also exhibit apathy. When overlooked in care settings, the consequences can be grave.
Blood tests that confirm Alzheimer’s disease expected soon
By
Alicia Lasek
Jul 16, 2019
A path to quicker and easier diagnosis seems near. Blood tests have the potential to replace costly and intrusive diagnostics.
Lifelong mental stimulation may prevent dementia, despite brain changes
By
Alicia Lasek
Jul 15, 2019
A lifetime of cognitively challenging activity is tied to lower dementia risk, even in people whose brains show signs of Alzheimer’s disease.
Chance of a senior developing Alzheimer’s has dropped 44% over the last three decades, large U.S....
By
Tim Mullaney
Jul 16, 2014
The odds of developing Alzheimer’s disease fell sharply among seniors in the United States over the last 30 years, according to research presented Tuesday at the Alzheimer’s Association International...
Avanir Pharmaceuticals releases data on PBA drug
Jul 01, 2014
Avanir Pharmaceuticals has announced data on pseudobulbar affect, a neurological condition characterized by disruptive, uncontrollable episodes of laughing or crying, and NUEDEXTA®, the only FDA-approved...
Sunlight treatment could help nighttime wandering in people with Alzheimer’s, study suggests
By
McKnight's Staff
Jul 27, 2012
The tendency of Alzheimer’s patients to wander at night could be tied to the quantity of daylight they’re exposed to, new research finds. As a result, experts say that “light therapy”...
Study: Experimental Alzheimer’s drug stabilizes symptoms for up to three years
Jul 24, 2012
Treatment with an experimental intravenous Alzheimer’s medication stabilized dementia symptoms for a sustained period in trial participants, new research reveals. Investigators called it a “first”...